Business Description
![GlobeStar Therapeutics Corp GlobeStar Therapeutics Corp logo](https://static.gurufocus.com/logos/0C00008EN4.png?14)
GlobeStar Therapeutics Corp
NAICS : 325412
SIC : 2834
ISIN : US03476L1026
Description
GlobeStar Therapeutics Corp is a clinical-stage Pharmaceutical Company introducing a patented formulation of previously approved drugs for the treatment of Multiple Sclerosis. The company is focused on developing therapies for people with serious and life-threatening rare disorders.
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Debt-to-Equity | -0.24 | |||||
Debt-to-EBITDA | -0.2 | |||||
Piotroski F-Score | N/A/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -26 | |||||
3-Year Book Growth Rate | 20.6 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 38.6 | |||||
9-Day RSI | 45.4 | |||||
14-Day RSI | 48.07 | |||||
6-1 Month Momentum % | -27.27 | |||||
12-1 Month Momentum % | -82.22 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History |
---|
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -31.7 | |||||
Shareholder Yield % | -33.76 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -0.7 | |||||
EV-to-EBITDA | -0.7 | |||||
EV-to-FCF | -6.2 | |||||
Earnings Yield (Greenblatt) % | -142.86 | |||||
FCF Yield % | -21.15 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:GSTC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
GlobeStar Therapeutics Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -0.002 | ||
Beta | 1.3 | ||
Volatility % | 113.84 | ||
14-Day RSI | 48.07 | ||
14-Day ATR ($) | 0.000189 | ||
20-Day SMA ($) | 0.00087 | ||
12-1 Month Momentum % | -82.22 | ||
52-Week Range ($) | 0.0004 - 0.0055 | ||
Shares Outstanding (Mil) | 1,241.11 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
GlobeStar Therapeutics Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
GlobeStar Therapeutics Corp Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
GlobeStar Therapeutics Corp Frequently Asked Questions
What is GlobeStar Therapeutics Corp(GSTC)'s stock price today?
The current price of GSTC is $0.00. The 52 week high of GSTC is $0.01 and 52 week low is $0.00.
When is next earnings date of GlobeStar Therapeutics Corp(GSTC)?
The next earnings date of GlobeStar Therapeutics Corp(GSTC) is .
Does GlobeStar Therapeutics Corp(GSTC) pay dividends? If so, how much?
GlobeStar Therapeutics Corp(GSTC) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |